Hundreds Of Women Have Reported Transvaginal Mesh Problems
Although the treatment has only been in steady use since 2008, hundreds of women have already reported transvaginal mesh problems. The nature of these complications and their high rate of occurrence have forced additional safety measures by the FDA, including small scale recalls for a number of slings. This treatment is used to correct stress urinary incontinence (SUI) or pelvic organ prolapse (POP), but the complications it can cause, can leave a patient in much worse condition.
In theory, these slings are supposed to provide additional support to the pelvic floor as women tend to experience muscle weakness in their lower abdomen following pregnancy. However, transvaginal mesh problems may emerge if the sling rubs up against soft tissues in the body, eroding them and leading to internal bleeding, organ failure, chronic pain, urinary complications and serious infections. In some cases, these complications can lead to infertility, and additional surgeries are almost always needed to correct the issue. This can expose a patient to even more complications and additional medical expenses.
Unfortunately, researchers have found a high incidence rate of complications arising from the procedure. Obstetrics & Gynecology published a study in 2010 that had to be cut short because too many women were experiencing side effects from the procedure. Even the FDA now recommends doctors only use the treatment when there are no other options.
Women who have been hurt by the procedure have a legal right to pursuing compensation for their injuries. Doctors and medical device manufacturers have a responsibility to their patients, and when this duty is not fulfilled, they must be held accountable.